搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Caulobacter crescentus Lipoprotein signal peptidase (lspA), partial CSB-YP857644DQO1
CSB-EP857644DQO1
CSB-BP857644DQO1
CSB-MP857644DQO1
CSB-EP857644DQO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus N-succinylglutamate 5-semialdehyde dehydrogenase 1 (astD1) CSB-YP857645DQO
CSB-EP857645DQO
CSB-BP857645DQO
CSB-MP857645DQO
CSB-EP857645DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Ribose-phosphate pyrophosphokinase (prs) CSB-YP857646DQO
CSB-EP857646DQO
CSB-BP857646DQO
CSB-MP857646DQO
CSB-EP857646DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Phosphoribosyl-AMP cyclohydrolase (hisI) CSB-YP857647DQO
CSB-EP857647DQO
CSB-BP857647DQO
CSB-MP857647DQO
CSB-EP857647DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) CSB-YP857648DQO
CSB-EP857648DQO
CSB-BP857648DQO
CSB-MP857648DQO
CSB-EP857648DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus tRNA pseudouridine synthase A (truA) CSB-YP857649DQO
CSB-EP857649DQO
CSB-BP857649DQO
CSB-MP857649DQO
CSB-EP857649DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Putative pterin-4-alpha-carbinolamine dehydratase (CC_0245) CSB-YP857650DQO
CSB-EP857650DQO
CSB-BP857650DQO
CSB-MP857650DQO
CSB-EP857650DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Uncharacterized signaling protein CC_0091 (CC_0091), partial CSB-YP857651DQO
CSB-EP857651DQO
CSB-BP857651DQO
CSB-MP857651DQO
CSB-EP857651DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Apolipoprotein N-acyltransferase (lnt), partial CSB-YP857652DQO1
CSB-EP857652DQO1
CSB-BP857652DQO1
CSB-MP857652DQO1
CSB-EP857652DQO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Molybdenum cofactor biosynthesis protein A (moaA) CSB-YP857653DQO
CSB-EP857653DQO
CSB-BP857653DQO
CSB-MP857653DQO
CSB-EP857653DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Putative phosphotransferase CC_0001 (CC_0001) CSB-YP857654DQO
CSB-EP857654DQO
CSB-BP857654DQO
CSB-MP857654DQO
CSB-EP857654DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor Phosphoadenosine phosphosulfate reductase (cysH) CSB-YP857655FOB
CSB-EP857655FOB
CSB-BP857655FOB
CSB-MP857655FOB
CSB-EP857655FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Malate synthase G (glcB), partial CSB-YP857656RDG
CSB-EP857656RDG
CSB-BP857656RDG
CSB-MP857656RDG
CSB-EP857656RDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus biovar 1 Peptidyl-tRNA hydrolase (pth) CSB-YP857657BWS
CSB-EP857657BWS
CSB-BP857657BWS
CSB-MP857657BWS
CSB-EP857657BWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative sugar transferase Nss (nss) CSB-YP857658SML
CSB-EP857658SML
CSB-BP857658SML
CSB-MP857658SML
CSB-EP857658SML-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Blue-light absorbing proteorhodopsin, partial CSB-YP857659GEAA1
CSB-EP857659GEAA1
CSB-BP857659GEAA1
CSB-MP857659GEAA1
CSB-EP857659GEAA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Amycolatopsis mediterranei Pyrophosphate--fructose 6-phosphate 1-phosphotransferase (pfp) CSB-YP857660BYK
CSB-EP857660BYK
CSB-BP857660BYK
CSB-MP857660BYK
CSB-EP857660BYK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phenylalanine--tRNA ligase beta subunit (pheT), partial CSB-YP857661FKZ
CSB-EP857661FKZ
CSB-BP857661FKZ
CSB-MP857661FKZ
CSB-EP857661FKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phosphoheptose isomerase (gmhA) CSB-YP857662AKAF
CSB-EP857662AKAF
CSB-BP857662AKAF
CSB-MP857662AKAF
CSB-EP857662AKAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant S-ribosylhomocysteine lyase (luxS) CSB-YP857663VFI
CSB-EP857663VFI
CSB-BP857663VFI
CSB-MP857663VFI
CSB-EP857663VFI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>